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Neurotrophin autocrine loops
Developing neurons depend on neurotrophins supplied by the tissues they
innervate. Before and after this period of target-dependent survival, brain-
derived neurotrophic factor also has autocrine actions on some neurons.
In the developing vertebrate nervous system, many neu-
rons die shortly after their axons reach their targets. This
loss is thought to match the number of neurons to the
size and requirements of their target fields, because alter-
ing target-field size prior to innervation affects the num-
ber of neurons that survive. Work on nerve growth factor
(NGF), the founder member of the neurotrophin family
of secreted proteins, has led to the widely accepted view
that target fields regulate their innervation density by pro-
ducing limited quantities of factors that the innervating
neurons require for their survival [1].
NGF is synthesized in the targets of NGF-dependent
sensory and sympathetic neurons in proportion to their
final innervation density, and experimental manipulation
of the level of NGF during development affects the
number of neurons that survive. Exogenous NGF rescues
neurons that would otherwise die, whereas anti-NGF
antibodies, or targeted null mutations in the genes enco-
ding NGF itself or the NGF receptor tyrosine kinase
eliminate NGF-dependent neurons. In addition to pro-
moting neuronal survival during development, target-
derived NGF also has a profound effect on regional
differences in axonal branching throughout life [2,3].
More recently identified neurotrophins - brain-derived
neurotrophic factor (BDNF), neurotrophin-3 (NT3) and
neurotrophin-4/5 (NT4/5) - also promote the survival
of distinctive sets of developing neurons [1].
The survival of sensory neurons depends on targetderived
neurotrophins for only a limited period during develop-
ment [1]. When cultured at low density during the stage
of development at which their axons are growing to their
targets, sensory neurons survive without added neuro-
trophins in the culture medium. At the stage when their
axons would have reached their targets in vivo, however,
the cultured sensory neurons die unless they are exposed
to the appropriate neurotrophin. Throughout the ensu-
ing phase of naturally occurring neuronal death, and for
some time beyond, different classes of sensory neurons
depend for their survival on the supply of one or more
specific neurotrophins [1]. By adulthood, dorsal root
ganglion (DRG) sensory neurons no longer require NGF
for survival in vivo [4] and can survive in vitro without
added NGF or BDNF [5].
Although various neurotrophins are expressed in the
peripheral and central targets of sensory neurons during
development [1], the discovery that mRNAs for BDNF
and NT3 are present in subsets of DRG neurons [6,7],
which themselves respond to these factors, has raised the
possibility that BDNF or NT3 could act by an autocrine
route. Studies using antisense BDNF oligonucleotides
to inhibit translation of BDNF mRNA in cultures of
DRG neurons have indeed provided evidence for the
operation of BDNF autocrine loops during periods of
target-independent survival.
A BDNF autocrine loop in early DRG neurons
The first direct experimental evidence that neurotro-
phins can act by an autocrine route came from studies of
DRG neurons cultured in vitro after isolation from chic-
ken embryos at the stage when their axons are growing
to their targets [8]. These early sensory neurons undergo
a clearly recognizable morphological transition during
the first 24 hours in culture, before they become depen-
dent on added neurotrophins for survival. Initially, the
neurons have small, spindle-shaped, phase-dark cell bod-
ies and short neurites. Subsequently, they develop spheri-
cal, phase-bright cell bodies and extend long neurites
(Fig. 1). Although the rate at which this maturational
change takes place is accelerated by exposure to either
BDNF or NT3, the neurons need not obtain these fac-
tors from other cells to mature - they still mature when
cultured as single cells in separate culture wells containing
chemically defined media without added neurotrophins.
Because early DRG cells express BDNF mRNA, as
revealed by amplification using the reverse transcription-
coupled polymerase chain reaction (RT-PCR), antisense
BDNF oligonucleotides were used to investigate whether
BDNF might act by an autocrine route to promote
maturation [8]. Each of three different antisense BDNF
oligonucleotides, but none of the corresponding sense
control oligonucleotides, reduced by 40-50 % the num-
ber of neurons that underwent the maturational change.
The inhibition of neuronal maturation by antisense
BDNF oligonucleotides was not due to a non-specific
reduction of protein synthesis, because the effect of the
oligonucleotides could be specifically reversed by adding
BDNF to the culture medium. The antisense BDNF
affected only the maturation of early DRG neurons and
not their survival, indicating that the BDNF autocrine
loop is not required for survival at this stage.
A BDNF autocrine loop in adult DRG neurons
Acheson and colleagues [9] have recently used a similar
experimental approach to demonstrate the operation of a
BDNF autocrine loop in adult DRG neurons. In contrast
to the situation in early sensory neurons, the BDNF
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Fig. 1. Photomicrographs of cultured DRG cells taken from a chicken embryo at embryonic day 4.5, showing the typical appearance of
(a,b) immature and (c) mature early sensory neurons. The paired immunofluorescence (a) and phase contrast (b) photomicrographs
demonstrate that immature neurons can be clearly distinguished from non-neuronal cells by staining with anti-neurofilament anti-
serum; two neurofilament-positive, spindle-shaped, immature neurons and one neurofilament-negative non-neuronal cell (arrow) are
shown. Scale bar = 50 FM. Reproduced with permission from [8].
autocrine loop at this stage appears to be required for the
survival of a subset of sensory neurons. Three antisense
BDNF oligonucleotides, but not the sense control oligo-
nucleotides, reduced the number of surviving neurons by
35 % in single-neuron cultures. To exclude the possibility
that this reduced neuronal survival was due to non-spe-
cific toxicity, these workers also showed that the effects of
antisense BDNF oligonucleotides could be reversed by
adding BDNF to the culture medium. However, in con-
trast to the very low concentrations of BDNF that are
sufficient completely to reverse the effects of antisense
BDNF oligonucleotides on early DRG neurons (20 pg
ml-1) [8], levels of BDNF almost four orders of magni-
tude higher were required to achieve complete reversal in
adult DRG neurons (100-200 ng ml-). Whether adult
DRG neurons are far less responsive to BDNF than devel-
oping neurons, or whether BDNF is acting as a neuro-
protectant at these very high concentrations, is unclear
from these experiments.
To exclude further the possibility of oligonucleotide toxi-
city, DRG cultures were set up from mice that are homo-
zygous for a null mutation in the BDNF gene. In these
cultures, antisense BDNF oligonucleotides did not reduce
the survival of the DRG neurons from one BDNF-defi-
cient animal, but they caused a 20-25 % reduction in the
survival of DRG neurons from another. Thus, the reduc-
tion in neuronal survival by antisense BDNF oligonu-
cleotides, which was associated with an 80 % reduction
in BDNF protein levels in these cultures, cannot be
attributed entirely to toxicity; rather it provides evidence
for the operation of a BDNF autocrine loop in a subset
of adult DRG neurons. Figure 2 illustrates the different
stages in the life history of sensory neurons during which
BDNF autocrine loops are likely to operate.
Do autocrine loops operate during the phase of neuronal
cell death?
The demonstration that BDNF mRNA is expressed in a
subset of embryonic DRG neurons during the period
when naturally occurring neuronal death is taking place
[7] has raised the possibility that BDNF might act by
an autocrine route in some neurons during this period
of development. But measurement of BDNF mRNA in
different populations of cranial sensory neurons that res-
pond to either NGF or BDNF has shown that, during
the phase of naturally occurring neuronal death, BDNF
mRNA is expressed predominantly in neurons that res-
pond to NGF, not BDNF (M. Robinson and A.M.D.,
unpublished observations). Furthermore, sensory neu-
rons die very rapidly at this stage when cultured without
neurotrophins [1]. Thus, during the period of naturally
occurring neuronal death, BDNF is unlikely to act by an
autocrine route in most sensory neurons. This makes
good sense, because an autocrine loop at this time would
interfere with the selection of neurons by target-derived
neurotrophins. It is possible, however, that the BDNF
made by NGF-dependent sensory neurons during this
stage acts on other cells, such as the neurons in the
central nervous system with which they synapse.
Although studies in vitro using antisense BDNF oligo-
nucleotides have provided compelling evidence for the
operation of BDNF autocrine loops in embryonic and
adult DRG neurons, the magnitude of the antisense
effects does not necessarily indicate how many neurons
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compare the results of these studies, because probes that
recognize different trkB variants were used, and because
in the former study trkB expression in the whole ganglion
was analyzed, whereas in the latter study trkB expression
was analyzed specifically in the subsets of neurons that
innervate different peripheral targets.
There remain a number of unresolved issues concerning
the postulated BDNF autocrine loop. In addition to as-
certaining how the loop is switched off and on, and
whether the same neurons that have an autocrine loop
early in development re-acquire this loop later on, it will
be important to determine whether BDNF acts intracel-
lularly, or whether it has to be secreted in order to act on
BDNF receptors. The use of specific BDNF-neutralizing
antisera added to the culture medium may help to clarify
this issue.
The expression of NT3 mRNA in a subset of DRG
neurons [6,7] raises the issue of whether NT3 autocrine
loops also operate in some sensory neurons. Consistent
with this possibility is the demonstration that the matura-
tion of early DRG neurons is accelerated by NT3 and
inhibited by antisense oligonucleotides that reduce expres-
sion of p75, a common low-affinity receptor for NT3 and
other neurotrophins [8]. Because each of the three anti-
sense p75 oligonucleotides used in this study was more
effective in preventing maturation than were antisense
BDNF oligonucleotides [8], it is possible that another p75
ligand, such as NT3, plays a role in promoting maturation.
Fig. 2. Stages in the life history of DRG sensory neurons when
BDNF autocrine loops are likely to operate. Before sensory neu-
rons have started to innervate their targets and become depen-
dent on target-derived neurotrophins for survival, a BDNF
autocrine loop accelerates an early maturational change in a pro-
portion of these neurons, but BDNF is not required for their sur-
vival at this stage. During the phase of naturally occurring
neuronal death, when the targets selectively support the survival
of the appropriate number of innervating neurons, the targets are
likely to be the most important source of BDNF for sensory neu-
rons. In the adult, when the neurons once again become inde-
pendent of target-derived neurotrophins for survival, a BDNF
autocrine loop promotes the survival of a subset of DRG neurons.
are involved. Because antisense BDNF oligonucleotides
may not inhibit the BDNF autocrine loop completely, it
is possible that the loop operates in more neurons than
are affected by the oligonucleotides. This implies that the
autocrine loop must be turned off in many neurons prior
to the phase of naturally occurring neuronal death, and
turned on again in many neurons at a later stage. This
might be achieved by regulating the expression of either
BDNF, its receptor TrkB, or both, in specific subsets of
DRG neurons during development. Detailed studies of
the numbers of DRG neurons expressing BDNF and
TrkB at different ages may help to resolve this question.
Analysis of trkB mRNA expression in rat DRG neurons
by in situ hybridization suggests that fewer neurons
express trkB mRNA in embryos and postnatal animals
[10] than in the adult [11]. However, it is difficult to
Using combined isotopic and non-isotopic in situ hybri-
dization, NGF mRNA and BDNF mRNA have been
colocalized with transcripts encoding their respective
receptor tyrosine kinases (TrkA and TrkB) in the same
neurons in several forebrain regions [12,13]. Among the
neurons that co-express BDNF and trkB mRNAs are a
major subset of cortical neurons [12,13]. This finding,
together with the demonstration that anti-BDNF anti-
serum reduces neuronal survival in cortical neuron cul-
tures [14], is consistent with the operation of a BDNF
autocrine loop in certain cortical neurons, but further
work will be required for it to be possible to exclude a
paracrine mode of action for BDNF
In addition to the co-expression of NGF and BDNF
with their cognate receptors in certain subsets of neurons
in the hippocampus, basal ganglia, cortex and hypothala-
mus, several other populations of neurons in the central
nervous system express neurotrophins and respond to the
same neurotrophins in culture. For example, dopamin-
ergic neurons of the substantia nigra express BDNF
mRNA and respond to BDNF with increased survival
[15], raising the possibility that BDNF may act by an
autocrine route in some of these neurons. Much work is
still needed to clarify how widely autocrine signalling
operates in the developing and mature nervous system
and to ascertain the significance of such signalling for
sustaining neuronal survival and regulating other aspects
of neuronal development and function.
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